Bo Zhou Manxiang Li Tianjun Chen Jianqing She
10.3389/fmed.2022.866068
Front Med (Lausanne)
2022 Jun 21;9:866068.
pd-l1 inhibitor durvalumab empyema lung squamous cell carcinoma myocarditis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35801208/
Case Reports
PMC9253414
35801208
Case Report: Acute Myocarditis Due to PD-L1 Inhibitor Durvalumab Monotherapy in a Patient With Lung Squamous Cell Carcinoma
2022